dorzolamide 20 MG/ML Ophthalmic Solution

What the CMS Formulary Data Shows for dorzolamide 20 MG/ML Ophthalmic Solution

Per the CMS 2026 Part D formulary file, dorzolamide 20 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 310015, generic name dorzolamide) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.7.

Real-world access to dorzolamide 20 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 710,453 Part D beneficiaries filled dorzolamide 20 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $81,680,075 and an average per-beneficiary annual cost of $114.97. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry dorzolamide 20 MG/ML Ophthalmic Solution today.